TOWNSEND RICHARD NOLAN (Chief Executive Officer) sold 6.4% of their position (25.95K shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $116.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2026ACC: 0001995218-26-000013
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+41.05K
Net shares
Net buyer
$116.2K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
67K acquired · 25.95K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+67K
Price / share
—
Trade value
—
% of position
19.9%
6/29/2026
336.76K→403.76K
Common Stock
Direct
Shares
−25.95K
Price / share
$4.48
Trade value
$116.24K
% of position
6.4%
7/1/2026
403.76K→377.82K
Total
Net shares
+41.05K
Net value
-$116.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2026 | A · Award | +67K | — | — | 19.9% | 336.76K | 403.76K |
| Common Stock Direct | 7/1/2026 | S · Sale | −25.95K | $4.48 | $116.24K | 6.4% | 403.76K | 377.82K |
| Total | +41.05K | -$116.24K | ||||||
Derivative Transactions0
No derivative transactions reported